Boehringer Ingelheim
How data and digital technologies can drive sustainability in pharma
December 16 by Adam JeffsWith pharma responsible for a significant share of global carbon emissions, pharma industry experts offer their advice on how pharma can curb its carbon-intensive actions
Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive
February 18 by Pharmaceuticals & Biotechnology EditorIn this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterf...
Pharmacovigilance is Not Just About Compliance
March 23 by Andrea CharlesDr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to r...
Why Changes are needed to Current Preformulation and Formulation Practices
March 15 by Andrea CharlesAs part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are...
Industry to Meet as MHRA, the Dutch Healthcare Inspectorate and the PDA Join 30 Industry Leaders Sharing their Views on Innovation in Clinical Trial Supply Practice and Regulations
November 03 by Pharma IQ NewsIn the wake of a transformed pharmaceutical market due to mergers and acquisitions, industry leaders are to converge in Rotterdam on 27th-28th January 2011, to discuss the latest push in cost cuttin...
2017: Preparing for the Falsified Medicines Directive
April 27 by Johannes SchoenJohannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive a...
Does the Future of Solubility Lie in HME?
April 27 by Pharma IQHot Melt Extrusion creates crystalline structures with finer particles. Anjali is principal research scientist at Boehringer Ingelheim. Anjali Angrawal, principal research scientist at...
Three Top Tips for Evaluating the Potential of New Drug Delivery Technologies
April 27 by Keith HorspoolDr. Keith Horspool, Vice President, Pharmaceutical Development US at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ, to discuss strategies to reduce time spent in R&D and recent...
Boehringer Ingelheim's Johannes Schoen on the Evolution of Pharma Logistics
April 27 by Pharmaceuticals & Biotechnology EditorIn this interview Johannes Schoen, Supply Network Quality Management Anti-counterfeiting, Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about how he sees pharma logistics evolvi...
Boehringer Ingelheim's Johannes Schoen on the Evolution of Pharma Logistics
April 27 by Pharmaceuticals & Biotechnology EditorIn this interview Johannes Schoen, Supply Network Quality Management Anti-counterfeiting, Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about how he sees pharma logistics evolvi...
Boehringer Ingelheim's Johannes Schoen on the Evolution of Pharma Logistics
April 27 by Pharmaceuticals & Biotechnology EditorIn this interview Johannes Schoen, Supply Network Quality Management Anti-counterfeiting, Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about how he sees pharma logistics evolvi...